The Susceptibility Testing Manufacturers Association presents an opinion for the delay of current susceptibility tests

Clinical Infectious Diseases

Volumn 63, Issue 11, 2016, Pages 1531-1532

  Kircher, Susan M ^a   Cullen, Sharon K ^b   Killian, Scott ^c   Zimmer, Barbara L ^b   Brasso, Bill B ^a  

^a BD Life Sciences   (United States)

^b BECKMAN COULTER INC   (United States)

^c Thermo Fisher Scientific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL SUSCEPTIBILITY TESTING; CLEARANCE; DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; HUMAN; LABORATORY TEST; LETTER; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORGANIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; ATTITUDE; MICROBIAL SENSITIVITY TEST;

ANTIFUNGAL AGENT;

ANTIFUNGAL AGENTS; ATTITUDE; MICROBIAL SENSITIVITY TESTS;

EID: 85014949637     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw602     Document Type: Letter

References (1)

1. Humphries RM, Hindler JA. Emerging resistance, new antimicrobial agents . . . but no tests! The challenge of antimicrobial susceptibility testing in the current US regulatory landscape. Clin Infect Dis 2016; 63:83-8.